+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CAMLINFINE

Camlin Fine Sciences Share Price

₹70.39 -0.72 (-1.01%)
New 52W Low today

20 Nov, 2026 3:54 PM (IST)

Camlin Fine Sciences live price: ₹70.39. It opened at ₹72 vs previous close ₹71; intraday high/low: ₹72/₹70. The 50 & 200 DMA stand at ₹87.50/₹116.60.

Camlin Fine Sciences Performance

  • Today's Low
  • ₹70
  • Today's High
  • ₹72
  • 52 Week Low
  • ₹70
  • 52 Week High
  • ₹192
  • Open Price₹72
  • Previous Close₹71
  • Volume552,357
  • 50 DMA₹87.50
  • 100 DMA₹99.10
  • 200 DMA₹116.60

Camlin Fine Sciences Chart

Investment Returns

  • Over 1 Month -23.16%
  • Over 3 Month -35.05%
  • Over 6 Month -41.93%
  • Over 1 Year -55.8%

Smart Investing Starts Here Start SIP with Camlin Fine Sciences for Steady Growth!

Invest Now

Camlin Fine Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -178.2
  • PEG Ratio
  • -2.4
  • Market Cap Cr
  • 1,352
  • P/B Ratio
  • 1.3
  • Average True Range
  • 3.6
  • EPS
  • -0.4
  • Dividend Yield
  • 0
  • MACD Signal
  • -4.8
  • RSI
  • 31.32
  • MFI
  • 18.91

Latest Stock News Updates

Camlin Fine Sciences Ltd - 532834 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November 13, 2026 for Ashish Subhash Dandekar

Camlin Fine Sciences Ltd - 532834 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 13, 2026 for Ashish Subhash Dandekar

Camlin Fine Sciences Ltd - 532834 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November 09, 2026 for Ashish Subhash Dandekar

Camlin Fine Sciences Financials

Camlin Fine Sciences Technicals

EMA & SMA

Current Price
₹70.39
-0.72 (-1.01%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹78.50
  • 50 Day
  • ₹87.50
  • 100 Day
  • ₹99.10
  • 200 Day
  • ₹116.60

Resistance and Support

70.46 Pivot Speed
  • R3 73.40
  • R2 72.40
  • R1 71.40
  • S1 69.40
  • S2 68.50
  • S3 67.50

Camlin Fine Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-03 Quarterly Results & Rights issue
2026-08-11 Quarterly Results
2026-05-26 Audited Results
2026-02-13 Quarterly Results
2025-11-10 Quarterly Results
Date Purpose Remarks
2012-02-17 Split

Camlin Fine Sciences Shareholding Pattern

48.03%
45.69%
4.97%
0.94%
0.36%

About Camlin Fine Sciences

Camlin Fine Sciences engaged in research, development, manufacturing and marketing of speciality chemicals, ingredients and additive blends. View More
  • NSE Symbol
  • CAMLINFINE
  • BSE Symbol
  • 532834
  • ISIN
  • INE052I01032

Similar Stocks to Camlin Fine Sciences

Camlin Fine Sciences FAQs

Camlin Fine Sciences share price is ₹70 As on 21 November, 2026 | 18:02

The Market Cap of Camlin Fine Sciences is ₹1352.2 Cr As on 21 November, 2026 | 18:02

The P/E ratio of Camlin Fine Sciences is -178.2 As on 21 November, 2026 | 18:02

The PB ratio of Camlin Fine Sciences is 1.3 As on 21 November, 2026 | 18:02

The 52 week High & Low of Camlin Fine Sciences is ₹192/₹69.5 respectively As on 21 November, 2026 | 18:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23